-
Something wrong with this record ?
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment
J. Salmanton-García, FA. Stewart, S. Heringer, M. Koniordou, E. Álvarez-Barco, CD. Argyropoulos, SC. Themistocleous, P. Valle-Simón, O. Spivak, L. Součková, C. Merakou, M. Amélia Mendonça, R. Joanna Davis, A. Maria Azzini, HH. Askling, S. Vene,...
Language English Country Netherlands
Document type Journal Article
NLK
ProQuest Central
from 2002-01-01 to 2 months ago
Nursing & Allied Health Database (ProQuest)
from 2002-01-01 to 2 months ago
Health & Medicine (ProQuest)
from 2002-01-01 to 2 months ago
Family Health Database (ProQuest)
from 2002-01-01 to 2 months ago
Health Management Database (ProQuest)
from 2002-01-01 to 2 months ago
Public Health Database (ProQuest)
from 2002-01-01 to 2 months ago
- MeSH
- COVID-19 * epidemiology prevention & control MeSH
- Child MeSH
- Volunteers MeSH
- Adult MeSH
- Clinical Trials as Topic * MeSH
- Humans MeSH
- Registries MeSH
- Patient Participation * MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Europe MeSH
INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic has evidenced the key role of vaccine design, obtention, production and administration to successfully fight against infectious diseases and to provide efficient remedies for the citizens. Although clinical trials were rapidly established during this pandemic, identifying suitable study subjects can be challenging. For this reason, the University Hospital Cologne established a volunteer registry for participation in clinical trials first in Germany, which has now been incorporated into the European VACCELERATE clinical trials network and grew to a European Volunteer Registry. As such, VACCELERATE's Volunteer Registry aims to become a common entry point for potential volunteers in future clinical trials in Europe. METHODS: Interested volunteers who would like to register for clinical trials in the VACCELERATE Volunteer Registry can access the registration questionnaire via http://www.vaccelerate.eu/volunteer-registry. Potential volunteers are requested to provide their current country and area of residence, contact information, including first and last name and e-mail address, age, gender, comorbidities, previous SARS-CoV-2 infection and vaccination status, and maximum distance willing to travel to a clinical trial site. The registry is open to both adults and children, complying with national legal consent requirements. RESULTS: As of May 2022, the questionnaire is available in 12 countries and 14 languages. Up to date, more than 36,000 volunteers have registered, mainly from Germany. Within the first year since its establishment, the VACCELERATE Volunteer Registry has matched more than 15,000 volunteers to clinical trials. The VACCELERATE Volunteer Registry will be launched in further European countries in the coming months. CONCLUSIONS: The VACCELERATE Volunteer Registry is an active single-entry point for European residents interested in COVID-19 clinical trials participation in 12 countries (i.e., Austria, Cyprus, Germany, Greece, Ireland, Lithuania, Norway, Portugal, Spain, Sweden and Turkey). To date, more than 15,000 registered individuals have been connected to clinical trials in Germany alone. The registry is currently in the implementation phase in 5 additional countries (i.e., Belgium, Czech Republic, Hungary, Israel and the Netherlands).
Centro Hospitalar Universitário do Porto Porto Portugal
Centro Nacional de Microbiología Instituto de Salud Carlos 3 Madrid Spain
Collaborative Center for Clinical Epidemiology and Outcomes Research Athens Greece
European University of Cyprus Nicosia Cyprus
European Vaccine Initiative Heidelberg Germany
German Centre for Infection Research Partner Site Bonn Cologne Cologne Germany
Haceteppe University Ankara Turkey
Hospital La Paz Institute for Health Research Madrid Spain
Influenza Centre Department of Clinical Science University of Bergen Bergen Norway
Medical University of Vienna Vienna Austria
Ministry of Health of Israel Jerusalem Israel
National Koranyi Institute for Pulmonology Budapest Hungary
Servicio Madrileño de Salud Madrid Spain
Université Paris Cité Assistance Publique Hopitaux de Paris Paris France
University of Verona Infectious Diseases Department of Diagnostic and Public Health Verona Italy
Vilnius University Hospital Santaros klinikos Vilnius University Medical Faculty Vilnius Lithuania
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22017825
- 003
- CZ-PrNML
- 005
- 20240206144556.0
- 007
- ta
- 008
- 220720s2022 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.vaccine.2022.05.022 $2 doi
- 035 __
- $a (PubMed)35659449
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Salmanton-García, Jon $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
- 245 10
- $a VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment / $c J. Salmanton-García, FA. Stewart, S. Heringer, M. Koniordou, E. Álvarez-Barco, CD. Argyropoulos, SC. Themistocleous, P. Valle-Simón, O. Spivak, L. Součková, C. Merakou, M. Amélia Mendonça, R. Joanna Davis, A. Maria Azzini, HH. Askling, S. Vene, P. Van Damme, A. Steinbach, G. Shiamakkides, D. Seidel, OF. Olesen, E. Noula, A. Macken, C. Luís, J. Leckler, O. Launay, C. Isitt, M. Hellemans, J. Frías-Iniesta, R. Di Marzo, AJ. Carcas, G. Boustras, AM. Borobia, I. Barta, K. Albus, M. Akova, J. Ochando, M. Cohen-Kandli, R. Jane Cox, P. Husa, L. Jancoriene, P. Mallon, L. Marques, SC. Mellinghoff, P. Nauclér, E. Tacconelli, K. Tóth, TE. Zaoutis, M. Zeitlinger, OA. Cornely, ZD. Pana, VACCELERATE consortium
- 520 9_
- $a INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic has evidenced the key role of vaccine design, obtention, production and administration to successfully fight against infectious diseases and to provide efficient remedies for the citizens. Although clinical trials were rapidly established during this pandemic, identifying suitable study subjects can be challenging. For this reason, the University Hospital Cologne established a volunteer registry for participation in clinical trials first in Germany, which has now been incorporated into the European VACCELERATE clinical trials network and grew to a European Volunteer Registry. As such, VACCELERATE's Volunteer Registry aims to become a common entry point for potential volunteers in future clinical trials in Europe. METHODS: Interested volunteers who would like to register for clinical trials in the VACCELERATE Volunteer Registry can access the registration questionnaire via http://www.vaccelerate.eu/volunteer-registry. Potential volunteers are requested to provide their current country and area of residence, contact information, including first and last name and e-mail address, age, gender, comorbidities, previous SARS-CoV-2 infection and vaccination status, and maximum distance willing to travel to a clinical trial site. The registry is open to both adults and children, complying with national legal consent requirements. RESULTS: As of May 2022, the questionnaire is available in 12 countries and 14 languages. Up to date, more than 36,000 volunteers have registered, mainly from Germany. Within the first year since its establishment, the VACCELERATE Volunteer Registry has matched more than 15,000 volunteers to clinical trials. The VACCELERATE Volunteer Registry will be launched in further European countries in the coming months. CONCLUSIONS: The VACCELERATE Volunteer Registry is an active single-entry point for European residents interested in COVID-19 clinical trials participation in 12 countries (i.e., Austria, Cyprus, Germany, Greece, Ireland, Lithuania, Norway, Portugal, Spain, Sweden and Turkey). To date, more than 15,000 registered individuals have been connected to clinical trials in Germany alone. The registry is currently in the implementation phase in 5 additional countries (i.e., Belgium, Czech Republic, Hungary, Israel and the Netherlands).
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a COVID-19 $x epidemiologie $x prevence a kontrola $7 D000086382
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a klinické zkoušky jako téma $7 D002986
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a zapojení pacienta $7 D010358
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a dobrovolní pracovníci $7 D014838
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Stewart, Fiona A $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
- 700 1_
- $a Heringer, Sarah $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
- 700 1_
- $a Koniordou, Markela $u Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece
- 700 1_
- $a Álvarez-Barco, Elena $u Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland
- 700 1_
- $a Argyropoulos, Christos D $u European University of Cyprus, Nicosia, Cyprus
- 700 1_
- $a Themistocleous, Sophia C $u European University of Cyprus, Nicosia, Cyprus
- 700 1_
- $a Valle-Simón, Paula $u Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain
- 700 1_
- $a Spivak, Orly $u Ministry of Health of Israel, Jerusalem, Israel
- 700 1_
- $a Součková, Lenka $u Masaryk University, Brno, Czech Republic, University Hospital Brno, Brno, Czech Republic, CZECRIN, Brno, Czech Republic $7 xx0204153
- 700 1_
- $a Merakou, Christina $u Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece
- 700 1_
- $a Amélia Mendonça, Maria $u Centro Hospitalar Universitário do Porto, Porto, Portugal
- 700 1_
- $a Joanna Davis, Ruth $u University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, Italy
- 700 1_
- $a Maria Azzini, Anna $u University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, Italy
- 700 1_
- $a Askling, Helena H $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
- 700 1_
- $a Vene, Sirkka $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
- 700 1_
- $a Van Damme, Pierre $u Universiteit Antwerpen, Faculty of Medicine and Health Science, VAXINFECTIO, Centre of Evaluation of Vaccination, Antwerp, Belgium
- 700 1_
- $a Steinbach, Angela $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
- 700 1_
- $a Shiamakkides, George $u European University of Cyprus, Nicosia, Cyprus
- 700 1_
- $a Seidel, Danila $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
- 700 1_
- $a Olesen, Ole F $u European Vaccine Initiative (EVI), Heidelberg, Germany
- 700 1_
- $a Noula, Evgenia $u European University of Cyprus, Nicosia, Cyprus
- 700 1_
- $a Macken, Alan $u Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland
- 700 1_
- $a Luís, Catarina $u European Vaccine Initiative (EVI), Heidelberg, Germany
- 700 1_
- $a Leckler, Janina $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
- 700 1_
- $a Launay, Odile $u Institut National de la Santé et de la Recherche Médicale-ANRS Maladies Infectieuses Émergentes, Paris, France; Université Paris Cité, Assistance Publique Hopitaux de Paris, Paris, France
- 700 1_
- $a Isitt, Catherine $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
- 700 1_
- $a Hellemans, Margot $u Universiteit Antwerpen, Faculty of Medicine and Health Science, VAXINFECTIO, Centre of Evaluation of Vaccination, Antwerp, Belgium
- 700 1_
- $a Frías-Iniesta, Jesús $u Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain
- 700 1_
- $a Di Marzo, Romina $u European Vaccine Initiative (EVI), Heidelberg, Germany
- 700 1_
- $a Carcas, Antonio J $u Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain
- 700 1_
- $a Boustras, George $u European University of Cyprus, Nicosia, Cyprus
- 700 1_
- $a Borobia, Alberto M $u Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain
- 700 1_
- $a Barta, Imre $u National Koranyi Institute for Pulmonology, Budapest, Hungary
- 700 1_
- $a Albus, Kerstin $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
- 700 1_
- $a Akova, Murat $u Haceteppe University, Ankara, Turkey
- 700 1_
- $a Ochando, Jordi $u Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
- 700 1_
- $a Cohen-Kandli, Miriam $u Ministry of Health of Israel, Jerusalem, Israel
- 700 1_
- $a Jane Cox, Rebecca $u Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway
- 700 1_
- $a Husa, Petr $u Masaryk University, Brno, Czech Republic, University Hospital Brno, Brno, Czech Republic, CZECRIN, Brno, Czech Republic
- 700 1_
- $a Jancoriene, Ligita $u Institute of Clinical Medicine, Medical Faculty, Vilnius University|Institute of Clinical Medicine, Medical Faculty, Vilnius University; Vilnius University Hospital Santaros klinikos, Vilnius University, Medical Faculty, Vilnius, Lithuania
- 700 1_
- $a Mallon, Patrick $u Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland
- 700 1_
- $a Marques, Laura $u Centro Hospitalar Universitário do Porto, Porto, Portugal
- 700 1_
- $a Mellinghoff, Sibylle C $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
- 700 1_
- $a Nauclér, Pontus $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
- 700 1_
- $a Tacconelli, Evelina $u University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, Italy
- 700 1_
- $a Tóth, Krisztina $u National Koranyi Institute for Pulmonology, Budapest, Hungary
- 700 1_
- $a Zaoutis, Theoklis E $u Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece
- 700 1_
- $a Zeitlinger, Markus $u Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Cornely, Oliver A $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, Germany
- 700 1_
- $a Pana, Zoi-Dorothea $u European University of Cyprus, Nicosia, Cyprus
- 710 2_
- $a VACCELERATE consortium
- 773 0_
- $w MED00004631 $t Vaccine $x 1873-2518 $g Roč. 40, č. 31 (2022), s. 4090-4097
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35659449 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20240206144553 $b ABA008
- 999 __
- $a ok $b bmc $g 1821762 $s 1169068
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 40 $c 31 $d 4090-4097 $e 20220602 $i 1873-2518 $m Vaccine $n Vaccine $x MED00004631
- LZP __
- $a Pubmed-20220720
